TXMD (STOCKS)
TherapeuticsMD, Inc.
$2.080000
+0.000000 (+0.00%)
Prev close: $2.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marlan D. Walker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24.55M
- Employees
- 1
- P/E (TTM)
- -110.05
- P/B (TTM)
- 0.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.13 | $-0.05 | -0.0790 | -154.90% |
|
Jun 2023 (Q2)
|
$-0.24 | $-0.07 | -0.1686 | -236.13% |
|
Mar 2023 (Q1)
|
$-0.37 | $0.06 | -0.4312 | -704.58% |
|
Dec 2022 (Q4)
|
$8.23 | $-1.13 | +9.3622 | +826.90% |
Financial Statements
| Revenues | $3.27M |
| Benefits Costs and Expenses | $3.53M |
| Costs And Expenses | $3.53M |
| Nonoperating Income/Loss | $3.69M |
| Operating Expenses | $7.22M |
| Depreciation and Amortization | $382.00K |
| Other Operating Expenses | $6.84M |
| Operating Income/Loss | -$3.95M |
| Income/Loss From Continuing Operations After Tax | -$295.00K |
| Income/Loss From Continuing Operations Before Tax | -$263.00K |
| Income/Loss From Discontinued Operations Net Of Tax | $78.00K |
| Net Income/Loss | -$217.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$217.00K |
| Net Income/Loss Available To Common Stockholders, Basic | -$217.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.02 |
| Diluted Earnings Per Share | -$0.02 |
| Basic Average Shares | 23,161,574 |
| Diluted Average Shares | 23,220,000 |
| Assets | $37.53M |
| Current Assets | $16.12M |
| Noncurrent Assets | $21.41M |
| Intangible Assets | $3.56M |
| Other Non-current Assets | $17.85M |
| Liabilities | $10.40M |
| Current Liabilities | $5.00M |
| Accounts Payable | $460.00K |
| Wages | $431.00K |
| Other Current Liabilities | $4.11M |
| Noncurrent Liabilities | $5.39M |
| Equity | $27.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.13M |
| Liabilities And Equity | $37.53M |
| Net Cash Flow From Operating Activities | $3.12M |
| Net Cash Flow From Operating Activities, Continuing | $3.10M |
| Net Cash Flow From Operating Activities, Discontinued | $23.00K |
| Net Cash Flow | $3.12M |
| Net Cash Flow, Continuing | $3.10M |
| Net Cash Flow, Discontinued | $23.00K |
| Comprehensive Income/Loss | -$217.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$217.00K |
| Other Comprehensive Income/Loss | $0.00 |